Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

An Abnormal Clone with a der(12;22)(q10;q10) as a Rare Abnormality Within the Context of dup(1)(q25q43), Deletion of ABL1 and a t(8;21) in a Pediatric Male Patient with Acute Myeloid Leukemia.

Journal of the Association of Genetic Technologists·2026
Same author

Complex Chromothripsis-like Features in Plasma Cell Myeloma: A Case Report and Review of the Literature.

Diagnostics (Basel, Switzerland)·2026
Same author

Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic stroke.

Cell metabolism·2026
Same author

Cannabidiol modulates spontaneous recovery through distinct and conserved transcriptomic signatures in mPFC subregions.

Communications biology·2026
Same author

Proteomic Profile After Intervention With Eplerenone Among Persons With HIV.

Open forum infectious diseases·2026
Same author

A Rare Case of De Novo Acute Myeloid Leukemia, Featuring a <i>KMT2A</i> (<i>MLL</i>) Amplification.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 24, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.5K

ETV6::RUNX1-like Acute Lymphoblastic Leukemia.

Anirudh Murthy1, Boyoung Lee2, Artemio Zavala3

  • 1Renaissance School of Medicine, Stony Brook, NY, USA.

Journal of the Association of Genetic Technologists
|June 2, 2024
PubMed
Summary

ETV6::RUNX1-like acute lymphoblastic leukemia (ALL) is a distinct B-cell precursor leukemia. This review covers its biomarkers, mutations, and prognosis, aiding in better management and accurate diagnosis.

More Related Videos

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.3K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

Related Experiment Videos

Last Updated: Jun 24, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.5K
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.3K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • ETV6::RUNX1-like acute lymphoblastic leukemia (ALL) is a recently identified subtype of B-cell precursor leukemia.
  • It shares characteristics with ETV6::RUNX1 ALL but lacks the specific fusion gene.
  • Understanding this subtype is crucial for refining leukemia classification and treatment strategies.

Purpose of the Study:

  • To review the existing literature on ETV6::RUNX1-like ALL.
  • To identify key biomarkers, common mutations, and prognostic factors associated with this leukemia subtype.
  • To highlight the importance of novel subcategorization in improving patient management and prognosis.

Main Methods:

  • Literature review of scientific articles and studies on ETV6::RUNX1-like ALL.
  • Analysis of data regarding genetic alterations, clinical features, and patient outcomes.
  • Synthesis of information on biomarkers and frequently associated mutations.

Main Results:

  • ETV6::RUNX1-like ALL represents a distinct entity within B-cell precursor ALL.
  • Specific biomarkers and recurrent mutations are associated with this subtype.
  • Prognostic implications of these findings are being elucidated.

Conclusions:

  • Accurate identification and characterization of ETV6::RUNX1-like ALL are essential for targeted therapies.
  • High-throughput genetic analysis aids in defining novel B-ALL subcategories.
  • Further research will refine management strategies and improve outcomes for patients with this leukemia.